The 'timing hypothesis' for estrogen therapy in menopausal symptom management

Women's Health

Volumn 11, Issue 4, 2015, Pages 437-440

  Manson, JoAnn E ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; ESTRADIOL; ESTROGEN; ESTROGEN DERIVATIVE; PLACEBO; TISSUE SELECTIVE ESTROGEN COMPLEX; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; BREAST CANCER; CANCER RISK; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CLINICAL DECISION MAKING; DRUG EFFICACY; DRUG MECHANISM; DRUG RESEARCH; DRUG SAFETY; EARLY INTERVENTION; EVIDENCE BASED MEDICINE; HEALTH CARE ACCESS; HIGH RISK POPULATION; HORMONAL THERAPY; HUMAN; LIFESTYLE MODIFICATION; MATERNAL AGE; MENOPAUSAL SYNDROME; MENOPAUSE; MOBILE APPLICATION; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SOCIAL STATUS; TREATMENT INDICATION; ADVERSE EFFECTS; BREAST TUMOR; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED; DRUG EFFECTS; ESTROGEN THERAPY; FEMALE; INTERVIEW; POLICY; PRACTICE GUIDELINE; PROCEDURES; TIME FACTOR; WOMEN'S HEALTH;

BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; POLICY; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; WOMEN'S HEALTH;

EID: 84939807582     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.15.24     Document Type: Review

References (10)

1. Grady D, Rubin SM, Petitti DB et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 117(12), 1016-1037 (1992
2. Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc. Res. 53(3), 605-619 (2002
3. North American Menopause S. The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause 19, 257-271 (2012
4. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science 308(5728), 1583-1587 (2005
5. Manson JE, Chlebowski RT, Stefanick ML et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA 310, 1353-1368 (2013
6. Manson JE, Allison MA, Rossouw JE et al. Estrogen therapy and coronary-Artery calcification. N. Engl. J. Med. 356, 2591-2602 (2007
7. Hodis HN, Shoupe D, Azen SP et al. Testing the menopausal hormone therapy timing hypothesis: the early versus late intervention trial with estradiol. Circulation 22(4), 391-401 2014
8. Harman SM, Black DM, Naftolin F et al. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann. Intern. Med. 161, 249-260 (2014
9. Manson JE. The role of personalized medicine in identifying appropriate candidates for menopausal estrogen therapy. Metabolism 62(Suppl. 1), S15-S19 (2013
10. Manson JE, Ames JM, Shapiro M et al. Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society. Menopause 22, 247-53 (2014